GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer

BACKGROUND: The interferon-induced protein known as guanylate-binding protein 2 (GBP2) has been linked to multiple different cancer types as an oncogenic gene. Although the role of GBP2 in cancer has been preliminarily explored, it is unclear how this protein interacts with tumor immunity in gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunfei, Pan, Jiadong, An, Fangmei, Chen, Ke, Chen, Jiawei, Nie, He, Zhu, Yanping, Qian, Zhengtao, Zhan, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544588/
https://www.ncbi.nlm.nih.gov/pubmed/37784054
http://dx.doi.org/10.1186/s12885-023-11308-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544588/
https://www.ncbi.nlm.nih.gov/pubmed/37784054
http://dx.doi.org/10.1186/s12885-023-11308-0

Ejemplares similares